Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Alpha-1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/19/2021 3 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Pralatrexate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/17/2021 2 0
P5A-1B6 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 1 0
P2B-1A10 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 1 0
P5A-2F11 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 1 0